GOED- 1847 Goedeker Inc $8.55 at Report Time BUY From 8 to 9.25 Spun out of a holding company in an IPO in summer 2020 at $10 per share to mostly retail investors, story is not followed yet but will be soon after a merger closes. -Dave Only...
SNSS 3.10 6-12 month target $8.25 plus Viracta Website Viracta is committed to advancing new medicines to benefit patients with viral-associated cancers and other serious diseases. Viracta’s proprietary platform is a highly targeted combination therapy approach for virus-associated malignancies. Our initial focus is on cancers associated with the Epstein...
MARA 22.50 88 Million shares after this direct offering closes this week at $20 per share Here are some more details on why I like this position as a defacto ETF of Bitcoin ownership if you will. At $22 MARA has a market cap of 1.95 Billion MARA can...
MARA $22 pre market down $4 I will post much more research and outlined details, but this is a fast mover and I have been waiting for a pullback. MARA is a Bitcoin miner and with Bitcoin as one of my ongoing growth themes, we can own...
BIVI near $12 as of 12/14/20 close Recent IPO in late September at $10 Max Entry 13, add all the way to 11.50 on near term dips Liver treatment indication that is de-risked and a potential promising Alzheimers indication added to pipeline in 2021 Target in...
MEEC .50 cents at time of report A Clean Energy play with massive upside, my targets are conservative MEEC December 2020 Investor Presentation (Click to download PDF) Shares outstanding 80 million Management owns 20% Market cap at 50 cents is 40 million Projected 2021 revenue is 47...
LTRN 17.50 Area 12 Month Target $48 The current market cap of LTRN, with the stock around $17 per share, is close to $125 million dollars based on 7.37 million shares outstanding. Managers and directors own 51% of fully diluted shares outstanding. Lantern collaborates with top academic and...
INMB- Inmune Bio $9.65 area Investing Advice: Buy from 9.50-10.50 ranges to accumulate a position Target is $25 plus in 6-12 months (Back to recent highs) Trading below the recent $10 secondar y offering and a gap fill area completed, this is the Tipping Point to buy the stock...
TBIO $16.30 area down from $28.09 highs in June on Sanofi news Tipping point to buy the stock after material drop following great news. Looks purely technical related and comes with insider buying.- Dave 67 Million shares outstanding, 1.1 billion market cap, 700 million cash. Translate Bio is...
TFFP $5.85 Area 8 Month POST IPO Breakout nigh About TFF Pharmaceuticals, Inc. TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. The Company believes, and early testing confirms, that...
indian xxnx horny desi indian cheating slime wife show boobs in webcam.
